AZ
VRTX icon

Alpha Zero’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpha Zero’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Buy
914
+229
+33% +$101K 0.17% 67
2026
Q1 		$306K Sell
685
-23
-3% -$10.7K 0.15% 62
2025
Q4 		$321K Sell
708
-27
-4% -$11.6K 0.18% 51
2025
Q3 		$288K Buy
735
+74
+11% +$30.9K 0.17% 51
2025
Q2 		$294K Buy
661
+56
+9% +$25.8K 0.19% 49
2025
Q1 		$293K Sell
605
-5
-0.8% -$2.33K 0.22% 50
2024
Q4 		$246K Buy
+610
New +$283K 0.18% 63

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Alpha Zero's VRTX Position: Q2 2026 in Review

Alpha Zero increased its Vertex Pharmaceuticals (VRTX) stake by 33% in Q2 2026, buying an estimated $101K and bringing the position to 914 shares worth $444K. The position accounts for 0.17% of the portfolio, ranked #67.

Alpha Zero first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Alpha Zero held 914 shares of Vertex Pharmaceuticals worth $444K as of Q2 2026.
  • Alpha Zero bought 229 Vertex Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Vertex Pharmaceuticals made up 0.17% of Alpha Zero's portfolio in Q2 2026, its #67 holding.
  • Alpha Zero first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Alpha Zero's 13F filing for Q2 2026, filed 20 Jul 2026.